Your browser doesn't support javascript.
loading
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Tison, Alice; Quéré, Gilles; Misery, Laurent; Funck-Brentano, Elisa; Danlos, François-Xavier; Routier, Emilie; Robert, Caroline; Loriot, Yohann; Lambotte, Olivier; Bonniaud, Bertille; Scalbert, Camille; Maanaoui, Sarah; Lesimple, Thierry; Martinez, Stéphanie; Marcq, Marie; Chouaid, Christos; Dubos, Catherine; Brunet-Possenti, Florence; Stavris, Chloé; Chiche, Laurent; Beneton, Nathalie; Mansard, Sandrine; Guisier, Florian; Doubre, Hélène; Skowron, François; Aubin, François; Zehou, Ouidad; Roge, Christophe; Lambert, Mickaël; Pham-Ledard, Anne; Beylot-Barry, Marie; Veillon, Rémi; Kramkimel, Nora; Giacchero, Damien; De Quatrebarbes, Julie; Michel, Catherine; Auliac, Jean-Bernard; Gonzales, Gilles; Decroisette, Chantal; Le Garff, Gwenaelle; Carpiuc, Ioana; Vallerand, Hervé; Nowak, Emmanuel; Cornec, Divi; Kostine, Marie.
Afiliación
  • Tison A; CHRU Brest, Brest, France.
  • Quéré G; CHRU Brest, Brest, France.
  • Misery L; CHRU Brest, Brest, France.
  • Funck-Brentano E; Hôpital Ambroise Paré Boulogne-Billancourt, AP-HP, Boulogne-Billancourt, France.
  • Danlos FX; Institut Gustave Roussy, Villejuif, France.
  • Routier E; Institut Gustave Roussy, Villejuif, France.
  • Robert C; Institut Gustave Roussy, Villejuif, France.
  • Loriot Y; Institut Gustave Roussy, Villejuif, France.
  • Lambotte O; Hôpital Kremlin-Bicêtre, AP-HP, Paris, France.
  • Bonniaud B; CHU Dijon, Dijon, France.
  • Scalbert C; CHU Lille, Lille, France.
  • Maanaoui S; CHU Lille, Lille, France.
  • Lesimple T; Centre Eugène Marquis, Rennes, France.
  • Martinez S; CH Aix-en-Provence, Aix-en-Provence, France.
  • Marcq M; CHD Vendée, La Roche-sur-Yon, France.
  • Chouaid C; CHI Créteil, Créteil, France.
  • Dubos C; Centre François Baclesse, Caen, France.
  • Brunet-Possenti F; CHU Bichat-Claude Bernard, AP-HP, Paris, France.
  • Stavris C; Hôpital Européen Marseille, Marseille, France.
  • Chiche L; Hôpital Européen Marseille, Marseille, France.
  • Beneton N; CH Le Mans, Le Mans, France.
  • Mansard S; CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France.
  • Guisier F; CHU Rouen, Rouen, France.
  • Doubre H; Hôpital Foch, Paris, France.
  • Skowron F; CH Valence, Valence, France.
  • Aubin F; CHU Besançon, Besançon, France.
  • Zehou O; Hôpital Henri Mondor, AP-HP, Créteil, France.
  • Roge C; CH Morlaix, Morlaix, France.
  • Lambert M; CH Morlaix, Morlaix, France.
  • Pham-Ledard A; CHU Bordeaux, Bordeaux, France.
  • Beylot-Barry M; CHU Bordeaux, Bordeaux, France.
  • Veillon R; CHU Bordeaux, Bordeaux, France.
  • Kramkimel N; Hôpital Cochin, AP-HP, Paris, France.
  • Giacchero D; Centre Antoine Lacassagne, Nice, France.
  • De Quatrebarbes J; CH Annecy Genevois, Metz-Tessy, France.
  • Michel C; Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, Mulhouse, France.
  • Auliac JB; CH Mantes-La-Jolie, Mantes-la-Jolie, France.
  • Gonzales G; CH Mâcon, Mâcon, France.
  • Decroisette C; CH Annecy Genevois, Metz-Tessy, France.
  • Le Garff G; CH Saint-Brieuc, Saint-Brieuc, France.
  • Carpiuc I; Capio Clinique des Cèdres, Cornebarrieu, France.
  • Vallerand H; CHU de Reims, Reims, France.
  • Nowak E; CHRU Brest, Brest, France.
  • Cornec D; CHRU Brest, Brest, France.
  • Kostine M; CHU Bordeaux, Bordeaux, France.
Arthritis Rheumatol ; 71(12): 2100-2111, 2019 12.
Article en En | MEDLINE | ID: mdl-31379105

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Antineoplásicos Inmunológicos / Inmunosupresores / Neoplasias Tipo de estudio: Etiology_studies / Evaluation_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Arthritis Rheumatol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Antineoplásicos Inmunológicos / Inmunosupresores / Neoplasias Tipo de estudio: Etiology_studies / Evaluation_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Arthritis Rheumatol Año: 2019 Tipo del documento: Article